Ocular Therapeutix (OCUL) Net Margin Growth (5y) (2019 - 2026)
Ocular Therapeutix (OCUL) Net Margin Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Ocular Therapeutix | 1.91 Bn | 1.91 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53,690.00 |
| Dec 31, 2025 | -29,061.00 |
| Sep 30, 2025 | -19,990.00 |
| Jun 30, 2025 | 74,741.00 |
| Mar 31, 2025 | 10,446.00 |
| Dec 31, 2024 | 56,370.00 |
| Sep 30, 2024 | 313,600.00 |
| Jun 30, 2024 | 553,553.00 |
| Mar 31, 2024 | 649,632.00 |
| Dec 31, 2023 | 322,489.00 |
| Sep 30, 2023 | 287,197.00 |
| Jun 30, 2023 | 198,661.00 |
| Mar 31, 2023 | 387,092.00 |
| Dec 31, 2022 | 257,446.00 |
| Sep 30, 2022 | 292,700.00 |
| Jun 30, 2022 | 428,353.00 |
| Mar 31, 2022 | 340,688.00 |
| Dec 31, 2021 | 233,075.00 |
| Sep 30, 2021 | 368,610.00 |
| Jun 30, 2021 | 240,853.00 |